The Competition Authority has this evening cleared the merger of Topaz and Statoil.

(PRWeb Oct 10, 2006)

BOSTON (Reuters) - Gilead Sciences Inc. , the world's third-biggest biotechnology company, said on Monday it has agreed to acquire Myogen Inc. for $2.5 billion in a surprise transaction that gives Gilead access to Myogen's experimental hypertension drugs.